UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025166
Receipt number R000028950
Scientific Title Changes in pulmonary function tests and respiratory symptoms after airway stent removal
Date of disclosure of the study information 2016/12/07
Last modified on 2021/10/21 23:16:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Changes in pulmonary function tests and respiratory symptoms after airway stent removal

Acronym

Pulmonary function after airway stent removal

Scientific Title

Changes in pulmonary function tests and respiratory symptoms after airway stent removal

Scientific Title:Acronym

Pulmonary function after airway stent removal

Region

Japan


Condition

Condition

Airway stenotic diseases

Classification by specialty

Pneumology Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate changes in pulmonary function and respiratory symptoms after vs. before airway stent removal

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

1. Changes in pulmonary function test results (peak expiratory flow) after vs. before airway stent removal

Key secondary outcomes

1. Changes in pulmonary function test results (FVC, FEV1) after airway stent removal
2. Changes in respiratory symptoms (frequency of coughing, amount of sputum, difficulty of expectoration, dyspnea) assessed by a visual analog scale after vs. before airway stent removal
3. Frequency of airway stent re-insertion
4. Incidence of adverse effects


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with an airway stent who require stent removal because of a response to tumor-specific therapy or stent-related respiratory symptoms
2. 20 years old or older
3. Informed consent

Key exclusion criteria

1. Patients expected to need stent re-insertion in the same setting as stent removal
2. Patients with multiple stents expected to undergo the removal of only some of them
3. Patients who cannot perform pulmonary function testing (e.g., patients with a tracheostomy or who are on mechanical ventilation)
4. Patients who cannot assess their respiratory symptoms using a visual analog scale
5. Patients who require stent removal due to stent migration
6. Patients who require bronchoscopic procedures other than stent removal (e.g., ablation of tumor or granulation tissue) in the same setting

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahide Oki

Organization

Nagoya Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan

TEL

052-951-1111

Email

masahideo@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Masahide Oki

Organization

Nagoya Medical Center

Division name

Department of Respiratory Medicine

Zip code


Address

4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan

TEL

052-951-1111

Homepage URL


Email

masahideo@gmail.com


Sponsor or person

Institute

Nagoya Medical Center

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 30 Day

Date of IRB

2016 Year 11 Month 30 Day

Anticipated trial start date

2016 Year 12 Month 07 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective consecutive study


Management information

Registered date

2016 Year 12 Month 06 Day

Last modified on

2021 Year 10 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028950


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name